The future of genetic association studies in Alzheimer disease

Journal of Neural Transmission

Volumn 110, Issue 3, 2003, Pages 253-266

  Finckh, U ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Alzheimer disease; Association; Candidate gene; Functional candidate gene; Linkage; Linkage disequilibrium; Positional candidate gene; SNP

Indexed keywords

APOLIPOPROTEIN E4; GENE PRODUCT;

ALLELISM; ALZHEIMER DISEASE; ARTICLE; CORRELATION ANALYSIS; FAMILIAL DISEASE; GENE CONTROL; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE MUTATION; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; QUANTITATIVE TRAIT; RISK FACTOR;

ALLELES; ALZHEIMER DISEASE; ANIMALS; GENETIC MARKERS; GENETICS, POPULATION; HUMANS; LINKAGE DISEQUILIBRIUM; QUANTITATIVE TRAIT LOCI; RISK FACTORS;

EID: 0037348113     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00702-002-0775-7     Document Type: Article

References (48)

1. Bergem AL, Engedal K, Kringlen E (1997) The role of heredity in late-onset Alzheimer disease and vascular dementia. A twin study. Arch Gen Psychiatry 54: 264-270
2. Bertram L, Tanzi RE (2001) Dancing in the dark? The status of late-onset Alzheimer's disease genetics. J Mol Neurosci 17: 127-136
3. Bertram L, Blacker D, Mullin K, Keeney D, Jones J, Basu S, Yhu S, McInnis MG, Go RC, Vekrellis K, Selkoe DJ, Saunders AJ, Tanzi RE (2000) Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. Science 290: 2302-2303
4. Blacker D, Wilcox MA, Laird NM, Rodes L, Horvath SM, Go RC, Perry R, Watson B Jr, Bassett SS, McInnis MG, Albert MS, Hyman BT, Tanzi RE (1998) Alpha-2 macro-globulin is genetically associated with Alzheimer disease. Nat Genet 19: 357-360
5. Corder EH, Saunders AM, Strittmatter WJ, Schmechel DE, Gaskell PC, Small GW, Roses AD, Haines JL, Pericak-Vance MA (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923
6. Devlin B, Roeder K (1999) Genomic control for association studies. Biometrics 55: 997-1004
7. Drigalenko E, Poduslo S, Elston R (1998) Interaction of the apolipoprotein E and CI loci in predisposing to late-onset Alzheimer's disease. Neurology 51: 131-135
8. Emahazion T, Feuk L, Jobs M, Sawyer SL, Fredman D, St. Clair D, Prince JA, Brookes AJ (2001) SNP association studies in Alzheimer's disease highlight problems for complex disease analysis. Trends Genet 17: 407-413
9. Ertekin-Taner N, Graff-Radford N, Younkin LH, Eckman C, Baker M, Adamson J, Ronald J, Blangero J, Hutton M, Younkin SG (2000) Linkage of plasma Abeta42 to a quantitative locus on chromosome 10 in late-onset Alzheimer's disease pedigrees. Science 290: 2303-2304
10. Evans DA, Beckett LA, Field TS, Feng L, Albert MS, Bennett DA, Tycko B, Mayeux R (1997) Apolipoprotein E epsilon4 and incidence of Alzheimer disease in a community population of older persons. Jama 277: 822-824
11. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, Myers RH, Pericak-Vance MA, Risch N, van Duijn CM (1997) Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. Jama 278: 1349-1356
12. Hardy J (2002) The real problem in association studies. Am J Med Genet 114: 253
13. Horvath S, Laird NM (1998) A discordant-sibship test for disequilibrium and linkage: no need for parental data. Am J Hum Genet 63: 1886-1897
14. Kamino K, Yoshiiwa A, Nishiwaki Y, Nagano K, Yamamoto H, Kobayashi T, Nonomura Y, Yoneda H, Sakai T, Imagawa M, Miki T, Ogihara T (1996) Genetic association study between senile dementia of Alzheimer's type and APOE/C1/C2 gene cluster. Gerontology 42 [Suppl 1]: 12-19
15. Kehoe P, Wavrant-De Vrieze F, Crook R, Wu WS, Holmans P, Fenton I, Spurlock G, Norton N, Williams H, Williams N, Lovestone S, Perez-Tur J, Hutton M, Chartier-Harlin MC, Shears S, Roehl K, Booth J, Van Voorst W, Ramic D, Williams J, Goate A, Hardy J, Owen MJ (1999) A full genome scan for late onset Alzheimer's disease. Hum Mol Genet 8: 237-245
16. Ki CS, Na DL, Kim DK, Kim HJ, Kim JW (2002) Genetic association of an apolipoprotein C-I (APOC1) gene polymorphism with late-onset Alzheimer's disease. Neurosci Lett 319: 75-78
17. Koster MN, Dermaut B, Cruts M, Houwing-Duistermaat JJ, Roks G, Tol J, Ott A, Hofman A, Munteanu G, Breteler MM, van Duijn CM, Van Broeckhoven C (2000). The alpha2-macroglobulin gene in AD: a population-based study and meta-analysis. Neurology 55: 678-684
18. Lambert JC, Goumidi L, Vrieze FW, Frigard B, Harris JM, Cummings A, Coates J, Pasquier F, Cottel D, Gaillac M, St. Clair D, Mann DM, Hardy J, Lendon CL, Amouyel P, Chartier-Harlin MC (2000a) The transcriptional factor LBP-1c/CP2/LSF gene on chromosome 12 is a genetic determinant of Alzheimer's disease. Hum Mol Genet 9: 2275-2280
19. Lambert JC, Mann D, Goumidi L, Harris J, Pasquier F, Frigard B, Cottel D, Lendon C, Iwatsubo T, Amouyel P, Chartier-Harlin MC (2000b) A FE65 polymorphism associated with risk of developing sporadic late-onset alzheimer's disease but not with Abeta loading in brains. Neurosci Lett 293: 29-32
20. Liao A, Nitsch RM, Greenberg SM, Finckh U, Blacker D, Albert M, Rebeck GW, Gomez-Isla T, Clatworthy A, Binetti G, Hock C, Mueller-Thomsen T, Mann U, Zuchowski K, Beisiegel U, Staehelin H, Growdon JH, Tanzi RE, Hyman BT (1998) Genetic association of an alpha2-macroglobulin (Val1000lle) polymorphism and Alzheimer's disease. Hum Mol Genet 7: 1953-1956
21. Martin ER, Lai EH, Gilbert JR, Rogala AR, Afshari AJ, Riley J, Finch KL, Stevens JF, Livak KJ, Slotterbeck BD, Slifer SH, Warren LL, Conneally PM, Schmechel DE, Purvis I, Pericak-Vance MA, Roses AD, Vance JM (2000) SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease. Am J Hum Genet 67: 383-394
22. Meyer JM, Breitner JC (1998) Multiple threshold model for the onset of Alzheimer's disease in the NAS-NRC twin panel. Am J Med Genet 81: 92-97
23. Myers A, Holmans P, Marshall H, Kwon J, Meyer D, Ramic D, Shears S, Booth J, DeVrieze FW, Crook R, Hamshere M, Abraham R, Tunstall N, Rice F, Carry S, Lillystone S, Kehoe P, Rudrasingham V, Jones L, Lovestone S, Perez-Tur J, Williams J, Owen MJ, Hardy J, Goate AM (2000) Susceptibility locus for Alzheimer's disease on chromosome 10. Science 290: 2304-2305
24. Olson JM, Goddard KA, Dudek DM (2001) The amyloid precursor protein locus and very-late-onset Alzheimer disease. Am J Hum Genet 69: 895-899
25. Pedersen NL, Posner SF, Gatz M (2001) Multiple-threshold models for genetic influences on age of onset for Alzheimer disease: findings in Swedish twins. Am J Med Genet 105: 724-728
26. Pericak-Vance MA, Bass MP, Yamaoka LH, Gaskell PC, Scott WK, Terwedow HA, Menold MM, Conneally PM, Small GW, Vance JM, Saunders AM, Roses AD, Haines JL (1997) Complete genomic screen in late-onset familial Alzheimer disease. Evidence for a new locus on chromosome 12. Jama 278: 1237-1241
27. Petit-Turcotte C, Stohl SM, Beffert U, Cohn JS, Aumont N, Tremblay M, Dea D, Yang L, Poirier J, Shachter NS (2001) Apolipoprotein C-I expression in the brain in Alzheimer's disease. Neurobiol Dis 8: 953-863
28. Poduslo SE, Neal M, Herring K, Shelly J (1998) The apolipoprotein CI A allele as a risk factor for Alzheimer's disease. Neurochem Res 23: 361-367
29. Pritchard JK, Rosenberg NA (1999) Use of unlinked genetic markers to detect population stratification in association studies. Am J Hum Genet 65: 220-228
30. Rall SC Jr, Weisgraber KH, Innerarity TL, Mahley RW (1982) Structural basis for receptor binding heterogeneity of apolipoprotein E from type III hyperlipoproteinemic subjects. Proc Natl Acad Sci USA 79: 4696-4700
31. Rao VS, Cupples A, van Duijn CM, Kurz A, Green RC, Chui H, Duara R, Auerbach SA, Volicer L, Wells J, van Broeckhoven C, Growdon JH, Haines JL, Farrer LA (1996) Evidence for major gene inheritance of Alzheimer disease in families of patients with and without apolipoprotein E epsilon 4. Am J Hum Genet 59: 664-675
32. Rebeck GW, Harr SD, Strickland DK, Hyman BT (1995) Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein E receptor, the alpha 2-macroglobulin receptor/low-density-lipoprotein receptor-related protein. Ann Neurol 37: 211-217
33. Risch N, Teng J (1998) The relative power of family-based and case-control designs for linkage disequilibrium studies of complex human diseases I. DNA pooling. Genome Res 8: 1273-1288
34. Rogaeva E, Premkumar S, Song Y, Sorbi S, Brindle N, Paterson A, Duara R, Levesque G, Yu G, Nishimura M, Ikeda M, O'Toole C, Kawarai T, Jorge R, Vilarino D, Bruni AC, Farrer LA, St. George-Hyslop PH (1998) Evidence for an Alzheimer disease susceptibility locus on chromosome 12 and for further locus heterogeneity. Jama 280: 614-618
35. Sanchez-Guerra M, Combarros O, Infante J, Llorca J, Berciano J, Fontalba A, Fernandez-Luna JL, Pena N, Fernandez-Viadero C (2001) Case-control study and meta-analysis of low density lipoprotein receptor-related protein gene exon 3 polymorphism in Alzheimer's disease. Neurosci Lett 316: 17-20
36. Schulze TG, McMahon FJ (2002) Genetic association mapping at the crossroads: which test and why? Overview and practical guidelines. Am J Med Genet 114: 1-11
37. Scott WK, Grubber JM, Conneally PM, Small GW, Hulette CM, Rosenberg CK, Saunders AM, Roses AD, Haines JL, Pericak-Vance MA (2000) Fine mapping of the chromosome 12 late-onset Alzheimer disease locus: potential genetic and phenotypic heterogeneity. Am J Hum Genet 66: 922-932
38. Slooter AJ, Cruts M, Kalmijn S, Hofman A, Breteler MM, Van Broeckhoven C, van Duijn CM (1998) Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. Arch Neurol 55: 964-968
39. Strittmatter WJ, Saunders AM, Schmechel D, Pericak-Vance M, Enghild J, Salvesen GS, Roses AD (1993) Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 90: 1977-1981
40. Taylor AE, Yip A, Brayne C, Easton D, Evans JG, Xuereb J, Cairns N, Esiri MM, Rubinsztein DC (2001) Genetic association of an LBP-1c/CP2/LSF gene polymorphism with late onset Alzheimer's disease. J Med Genet 38: 232-233
41. Tol J, Slooter AJC, van Duijn CM (1999) Genetic factors in early- and late-onset Alzheimer's disease: In: Mayeux R, Christen Y (eds) Epidemiology of Alzheimer's disease: from gene to prevention. Springer, Berlin Heidelberg New York Tokyo, pp 33-39
42. Tysoe C, Galinsky D, Robinson D, Brayne C, Huppert FA, Dening T, Paykel ES, Easton DF, Rubinsztein DC (1998) Apo E and Apo CI loci are associated with dementia in younger but not older late-onset cases. Dement Geriatr Cogn Disord 9: 191-198
43. Van Leuven F, Stas L, Hilliker C, Lorent K, Umans L, Serneels L, Overbergh L, Torrekens S, Moechars D, De Strooper B, Van den Berghe H (1994) Structure of the gene (LRP1) coding for the human alpha 2-macroglobulin receptor lipoprotein receptor-related protein. Genomics 24: 78-89
44. Warwick Daw E, Payami H, Nemens EJ, Nochlin D, Bird TD, Schellenberg GD, Wijsman EM (2000) The number of trait loci in late-onset Alzheimer disease. Am J Hum Genet 66: 196-204
45. Weisgraber KH, Innerarity TL, Mahley RW (1982) Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site. J Biol Chem 257: 2518-2521
46. Wright AF, Carothers AD, Pirastu M (1999) Population choice in mapping genes for complex diseases. Nat Genet 23: 397-404
47. Wu WS, Holmans P, Wavrant-DeVrieze F, Shears S, Kehoe P, Crook R, Booth J, Williams N, Perez-Tur J, Roehl K, Fenton I, Chartier-Harlin MC, Lovestone S, Williams J, Hutton M, Hardy J, Owen MJ, Goate A (1998) Genetic studies on chromosome 12 in late-onset Alzheimer disease. JAMA 280: 619-622
48. Zubenko GS, Hughes HB, Stiffler JS, Hurtt MR, Kaplan BB (1998) A genome survey for novel Alzheimer disease risk loci: results at 10-cM resolution. Genomics 50: 121-128